This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimers disease
- Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognition
- Tau pathology leads to lonely non-traveling slow waves that mediate human memory impairment
- Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimers disease
- Effect of Alzheimer's Pathology on Task-Related Brain Network Reconfiguration in Aging
- Pathological brain states in Alzheimers disease
- Striatal dopamine synthesis and cognitive flexibility differ between hormonal contraceptive users and non-users
- Brain and systemic inflammation in de novo Parkinsons disease
- Association of {beta}-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy
- Causal links among amyloid, tau, and neurodegeneration
- The heritability of amyloid burden in older adults: the Older Australian Twins Study
- Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults
- Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET
- Metacognition, cortical thickness, and tauopathy in aging
- Hippocampal Connectivity with Retrosplenial Cortex is Linked to Neocortical Tau Accumulation and Memory Function
- Tau and {beta}-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep
- Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
- [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease
- Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe
- Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy
- In Vivo Cortical Microstructure: A Proxy for Tauopathy and Cognitive impairment in the Elderly with and without MCI/Dementia
- Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults
- Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
- Patient-centered connectivity-based prediction of tau pathology spread in Alzheimers disease
- Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid
- What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy
- A{beta} deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimers disease
- Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism
- Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients
- Differential regional decline in dopamine receptor availability across adulthood: Linear and nonlinear effects of age
- Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
- Sleep as a Potential Biomarker of Tau and {beta}-Amyloid Burden in the Human Brain
- Reproducibility of the correlative triad among aging, dopamine receptor availability, and cognition
- Development of a mnemonic discrimination task using naturalistic stimuli with applications to aging and preclinical Alzheimer's disease
- CSF biomarkers are differentially related to structural and functional changes in dementia of the Alzheimers type
- Associations between tau, A{beta}, and cortical thickness with cognition in Alzheimer disease
- An Efficient Approach to Perform MR-Assisted PET Data Optimization in Simultaneous PET/MR Neuroimaging Studies
- Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity
- Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimers disease
- Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB1R Levels
- Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
- 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test-Retest Reproducibility and Quantification of Neuroinflammation
- Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions
- Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
- Subthreshold Amyloid Predicts Tau Deposition in Aging
- Lower Limbic Metabotropic Glutamate Receptor 5 Availability in Alcohol Dependence
- Optimizing Image Quantification for 177Lu SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom
- In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease
- Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging
- Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis
- 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
- Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals
- Tau and {beta}-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging
- Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility
- Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study
- Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies
- Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
- Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times
- Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben {beta}-Amyloid PET Scans
- Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies
- Variability and Uncertainty of 18F-FDG PET Imaging Protocols for Assessing Inflammation in Atherosclerosis: Suggestions for Improvement
- Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies
- Principles of PET/MR Imaging
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- PET imaging shows loss of striatal PDE10A in patients with Huntington disease
- New Approach to Quantification of Molecularly Targeted Radiotracer Uptake from Hybrid Cardiac SPECT/CT: Methodology and Validation
- PET/MRI for Neurologic Applications
- MR Imaging-Based Correction for Partial Volume Effect Improves Detectability of Intractable Epileptogenic Foci on Iodine 123 Iomazenil Brain SPECT Images: An Extended Study with a Larger Sample Size
- Risk Stratification of Gallbladder Polyps (1-2 cm) for Surgical Intervention with 18F-FDG PET/CT
- Brain Glucose Metabolism in Vascular White Matter Disease With Dementia: Differentiation From Alzheimer Disease
- In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with 99mTc-Folate SPECT/CT
- Carotid Plaque Inflammation Is Associated With Cerebral Microembolism in Patients With Recent Transient Ischemic Attack or Stroke: A Pilot Study
- Using Cerebral White Matter for Estimation of Nondisplaceable Binding of 5-HT1A Receptors in Temporal Lobe Epilepsy
- Muscarinic Receptor Upregulation in Patients With Myocardial Infarction: A New Paradigm
- Dopamine Release in Dissociable Striatal Subregions Predicts the Different Effects of Oral Methylphenidate on Reversal Learning and Spatial Working Memory
- Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods
- Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?
- Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET
- Voxel-Based Analysis of 11C-PIB Scans for Diagnosing Alzheimer's Disease
- Design and Implementation of an Automated Partial Volume Correction in PET: Application to Dopamine Receptor Quantification in the Normal Human Striatum
- Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease
- Latest Advances in Molecular Imaging Instrumentation
- Partial-Volume Effect in PET Tumor Imaging
- Partial-Volume Correction in PET: Validation of an Iterative Postreconstruction Method with Phantom and Patient Data
- Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease
- A 18F-MPPF PET Normative Database of 5-HT1A Receptor Binding in Men and Women Over Aging
- Brain Incorporation of 11C-Arachidonic Acid, Blood Volume, and Blood Flow in Healthy Aging: A Study With Partial-Volume Correction
- Integrated Software for the Analysis of Brain PET/SPECT Studies with Partial-Volume-Effect Correction
- Quantitative Accuracy of Dopaminergic Neurotransmission Imaging with 123I SPECT